SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/09/21 Iovance Biotherapeutics, Inc. 424B5 1:799K Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 424B5 Prospectus - Primary Offering or Shelf Securities HTML 266K - New Facts or Events
tm215806-1_424b5 - none - 4.2029866s |
| | ||||||||||||||
Title of Each Class of Securities to be Registered
|
| | |
Proposed
Maximum Aggregate Offering Price |
| | |
Amount of
Registration Fee(1) |
| ||||||
Common Stock, $0.000041666 par value per share
|
| | | | $ | 350,000,000 | | | | | | $ | 38,185(1) | | |
| | |
Page
|
| |||
Prospectus Supplement | | | | | | | |
| | | | S-ii | | | |
| | | | S-iii | | | |
| | | | S-1 | | | |
| | | | S-7 | | | |
| | | | S-9 | | | |
| | | | S-10 | | | |
| | | | S-12 | | | |
| | | | S-12 | | | |
| | | | S-12 | | | |
| | | | S-13 | | | |
Prospectus
|
| |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 4 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 12 | | | |
| | | | 20 | | | |
| | | | 21 | | | |
| | | | 22 | | | |
| | | | 24 | | | |
| | | | 26 | | | |
| | | | 26 | | | |
| | | | 26 | | | |
| | | | 27 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 4 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 12 | | | |
| | | | 20 | | | |
| | | | 21 | | | |
| | | | 22 | | | |
| | | | 24 | | | |
| | | | 26 | | | |
| | | | 26 | | | |
| | | | 26 | | | |
| | | | 27 | | |
This ‘424B5’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 2/9/21 | 8-K | ||
2/8/21 | 8-K | |||
2/5/21 | ||||
10/16/20 | ||||
9/30/20 | 10-Q | |||
6/30/20 | 10-Q | |||
5/29/20 | 424B5, 8-K | |||
5/27/20 | 424B5, 8-K, S-3ASR | |||
5/26/20 | ||||
3/31/20 | 10-Q | |||
3/16/20 | ||||
12/31/19 | 10-K | |||
6/1/19 | ||||
12/31/18 | 10-K | |||
List all Filings |